MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic lung disease associated with substantial morbidity and mortality. The objective of this study was to determine whether there is a peripheral blood protein signature in IPF and whether components of this signature may serve as biomarkers for disease presence and progression. METHODS AND FINDINGS: We analyzed the concentrations of 49 proteins in the plasma of 74 patients with IPF and in the plasma of 53 control individuals. We identified a combinatorial signature of five proteins-MMP7, MMP1, MMP8, IGFBP1, and TNFRSF1A-that was sufficient to distinguish patients from controls with a sensitivity of 98.6% (95% confidence interval [CI] 92.7%-100%) and specificity of 98.1% (95% CI 89.9%-100%). Increases in MMP1 and MMP7 were also observed in lung tissue and bronchoalveolar lavage fluid obtained from IPF patients. MMP7 and MMP1 plasma concentrations were not increased in patients with chronic obstructive pulmonary disease or sarcoidosis and distinguished IPF compared to subacute/chronic hypersensitivity pneumonitis, a disease that may mimic IPF, with a sensitivity of 96.3% (95% CI 81.0%-100%) and specificity of 87.2% (95% CI 72.6%-95.7%). We verified our results in an independent validation cohort composed of patients with IPF, familial pulmonary fibrosis, subclinical interstitial lung disease (ILD), as well as with control individuals. MMP7 and MMP1 concentrations were significantly higher in IPF patients compared to controls in this cohort. Furthermore, MMP7 concentrations were elevated in patients with subclinical ILD and negatively correlated with percent predicted forced vital capacity (FVC%) and percent predicted carbon monoxide diffusing capacity (DLCO%). CONCLUSIONS: Our experiments provide the first evidence for a peripheral blood protein signature in IPF to our knowledge. The two main components of this signature, MMP7 and MMP1, are overexpressed in the lung microenvironment and distinguish IPF from other chronic lung diseases. Additionally, increased MMP7 concentration may be indicative of asymptomatic ILD and reflect disease progression.

Cited by papers we hold 19

• Predictors of long-term prognosis in rheumatoid arthritis-related interstitial lung disease · 2022
  Not checked
• Early IL-17A production helps establish Mycobacterium intracellulare infection in mice. · 2022
  Not checked
• Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis · 2022
  Not checked
• Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement · 2022
  No notice
• Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches · 2022
  No notice
• Plasma proteomic biomarker signature of age predicts health and life span · 2020
  No notice
• A proteomic atlas of senescence-associated secretomes for aging biomarker development · 2020
  No notice
• SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis · 2020
  No notice
• The Versatile Role of Matrix Metalloproteinase for the Diverse Results of Fibrosis Treatment · 2019
  Not checked
• The natural history of progressive fibrosing interstitial lung diseases · 2019
  No notice
• Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study · 2019
  No notice
• Idiopathic Pulmonary Fibrosis (IPF): An Overview · 2018
  No notice
• Macrophages: friend or foe in idiopathic pulmonary fibrosis? · 2018
  No notice
• Blood Biomarkers in Idiopathic Pulmonary Fibrosis · 2017
  No notice
• Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis · 2016
  No notice
• Diverse functions of matrix metalloproteinases during fibrosis · 2014
  No notice
• Global Methylation Patterns in Idiopathic Pulmonary Fibrosis · 2012
  No notice
• Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle · 2011
  No notice
• Molecular Phenotypes Distinguish Patients with Relatively Stable from Progressive Idiopathic Pulmonary Fibrosis (IPF) · 2009
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.